Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 41 - 60 of 485 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of Dabrafenib and Ipilimumab with and without Trametinib for Advanced Melanoma
[Protocol 12-285]
Callahan, Margaret
  • Melanoma
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret
  • Cervical Cancer
  • Colorectal Cancer
  • Head & Neck Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Solid Tumors
A Pilot Trial of PET Imaging with (89)Zr-DFO-Trastuzumab in Esophagogastric Cancer
[Protocol 13-165]
Carrasquillo, Jorge
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Study of Non-Hormonal Vaginal Moisturizer in Hormone Receptor-Positive Postmenopausal Cancer Survivors
[Protocol 12-232]
Carter, Jeanne
  • Breast Cancer
  • Survivorship
A Phase Ib Study of AEB071 and MEK162 in Patients with Advanced Uveal Melanoma
[Protocol 13-172]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase I Study of BVD-523 in Patients with Advanced Cancers
[Protocol 13-254]
Carvajal, Richard
  • Melanoma
  • Solid Tumors
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083]
Carvajal, Richard
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Trametinib with and without GSK2141795 in Patients with Advanced Uveal Melanoma
[Protocol 13-144]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of Vorinostat for Metastatic Uveal Melanoma
[Protocol 12-027]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie
  • Breast Cancer
  • Quality of Life
  • Survivorship
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma
[Protocol 06-150]
Castro-Malaspina, Hugo
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Phase I Study of LOR-253 in Patients with Advanced or Metastatic Solid Tumors
[Protocol 09-021]
Cercek, Andrea
A Phase I Study of Hepatic Arterial Infusion with Floxuridine, Dexamethasone, and Gemcitabine after Surgery for Liver Cholangiocarcinoma
[Protocol 13-148]
Cercek, Andrea
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106]
Chaft, Jamie
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of MPDL3280A in Patients with PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
[Protocol 13-084]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163]
Chandarlapaty, Sarat
  • Breast Cancer
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Subjects with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005]
Chandarlapaty, Sarat
  • Breast Cancer